SD Biosensor, Inc (KRX:137310)

Market Cap	1.30T
Revenue (ttm)	674.07B
Net Income (ttm)	-63.22B
Shares Out	122.35M
EPS (ttm)	-516.68
PE Ratio	n/a
Forward PE	n/a
Dividend	200.00 (1.85%)
Ex-Dividend Date	Dec 27, 2024

Volume	128,292
Average Volume	203,389
Open	10,540
Previous Close	10,580
Day's Range	10,400 - 10,800
52-Week Range	7,870 - 15,340
Beta	0.88
RSI	43.32
Earnings Date	Feb 20, 2025

About SD Biosensor

SD Biosensor, Inc, an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company’s products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decis...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Employees: 576
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 137310